{
    "clinical_study": {
        "@rank": "11430", 
        "arm_group": [
            {
                "arm_group_label": "Fentanyl IV PCA and placebo TAP catheter", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients will receive Fentanyl IV PCA and placebo TAP catheter."
            }, 
            {
                "arm_group_label": "TAP catheter with continuous infusion of Ropivicaine", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive TAP catheter with continuous infusion of Ropivicaine for up to 48 hours after surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "Up to 174 patients undergoing renal transplantation will be randomized to one of two groups.\n       Randomization will be based on computer-generated codes using random block sizes ranging\n      from 4 to 8.\n\n      Group 1:   TAP catheter with continuous infusion of Ropivicaine Group 2:   Fentanyl IV PCA\n\n      The TAP catheter will be removed 48 hours postoperatively. Following removal, the pain\n      scores will be assessed at 60 and 72 hours postoperatively to determine any prolonged\n      analgesic benefit.  In addition, the presence of any pain at the incision site will be noted\n      at the 1 month surgical follow-up to determine any evidence of chronic pain.\n\n      The investigators hypothesis is that unilateral kidney transplant patients with a continuous\n      TAP catheter will have decreased pain scores and opioid usage compared to those receiving\n      standard analgesic therapy."
        }, 
        "brief_title": "The Effects of Continuous Transversus Abdominis Plane (TAP) Catheters on Postoperative Pain After Renal Transplantation", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient is >18 years of age\n\n          -  The patient has provided written informed consent and understands the explanation of\n             the protocol.\n\n          -  The patient is scheduled to have a unilateral renal transplant with a flank incision\n\n        Exclusion Criteria:\n\n          -  Patients aged <18.\n\n          -  Patients with a known allergy to amide local anesthetics or para-aminobenzoic acid.\n\n          -  Patients who are unable to understand the verbal analog pain scale.\n\n          -  Patients who decline participation.\n\n          -  Patients with a midline abdominal incision.\n\n          -  Combined transplants, ie. Kidney-pancreas"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "174", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679106", 
            "org_study_id": "12-559"
        }, 
        "intervention": [
            {
                "arm_group_label": "TAP catheter with continuous infusion of Ropivicaine", 
                "description": "Patients will receive TAP catheter with continuous infusion of Ropivicaine.", 
                "intervention_name": "TAP catheter with Ropivicaine", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Fentanyl IV PCA and placebo TAP catheter", 
                "description": "Patients will receive placebo TAP catheter with Fentanyl IV PCA.", 
                "intervention_name": "Fentanyl IV PCA and placebo TAP catheter", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Fentanyl"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "renal transplant", 
            "flank incision"
        ], 
        "lastchanged_date": "February 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cleveland", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44195"
                }, 
                "name": "Cleveland Clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "The Cleveland Clinic", 
            "last_name": "Ehab Farag, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The primary objective is to evaluate the influence of a continuous TAP analgesia on postoperative analgesia (as defined by pain scores and opioid requirements) in patients undergoing renal transplantation, compared to standard analgesic management (IV PCA).", 
                "measure": "Effect of continuous TAP analgesia and pain scores", 
                "safety_issue": "No", 
                "time_frame": "day 1"
            }, 
            {
                "description": "The primary objective is to evaluate the influence of a continuous TAP analgesia on postoperative analgesia (as defined by pain scores and opioid requirements) in patients undergoing renal transplantation, compared to standard analgesic management (IV PCA).", 
                "measure": "Effect of TAP analgesia and opioid requirements", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "The primary objective is to evaluate the influence of a continuous TAP analgesia on postoperative analgesia (as defined by pain scores and opioid requirements) in patients undergoing renal transplantation, compared to standard analgesic management (IV PCA).", 
                "measure": "Effect of continuous TAP analgesia on pain scores", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "description": "The primary objective is to evaluate the influence of a continuous TAP analgesia on postoperative analgesia (as defined by pain scores and opioid requirements) in patients undergoing renal transplantation, compared to standard analgesic management (IV PCA).", 
                "measure": "effect of continuous TAP analgesia on pain scores", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }, 
            {
                "description": "The primary objective is to evaluate the influence of a continuous TAP analgesia on postoperative analgesia (as defined by pain scores and opioid requirements) in patients undergoing renal transplantation, compared to standard analgesic management (IV PCA).", 
                "measure": "Effect of continuous TAP analgesia on pain scores", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "description": "The primary objective is to evaluate the influence of a continuous TAP analgesia on postoperative analgesia (as defined by pain scores and opioid requirements) in patients undergoing renal transplantation, compared to standard analgesic management (IV PCA).", 
                "measure": "Effect of TAP analgesia on opioid requirements", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "description": "The primary objective is to evaluate the influence of a continuous TAP analgesia on postoperative analgesia (as defined by pain scores and opioid requirements) in patients undergoing renal transplantation, compared to standard analgesic management (IV PCA).", 
                "measure": "Effect of TAP analgesia on opioid requirements", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }, 
            {
                "description": "The primary objective is to evaluate the influence of a continuous TAP analgesia on postoperative analgesia (as defined by pain scores and opioid requirements) in patients undergoing renal transplantation, compared to standard analgesic management (IV PCA).", 
                "measure": "Effect of TAP analgesia on opioid requirements", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679106"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "The Cleveland Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Cleveland Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}